angiotensin ii has been researched along with sulforaphane in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 5 (55.56) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, J; Fang, Y; Gao, L; Ma, ZG; Tang, QZ; Wu, QQ; Xu, M; Yang, Z; Zong, J | 1 |
| Bai, Y; Cai, L; Kong, L; Liu, F; Tan, Y; Wang, Y; Wu, H; Xin, Y | 1 |
| Bai, Y; Cai, L; Cui, T; Ji, H; Jiang, X; Tan, Y; Wang, Y; Wintergerst, KA; Xin, Y; Zhou, S | 1 |
| Jiang, L; Qiu, Z; Xu, Y; Zhang, M | 1 |
| Gao, L; Ma, A; Rudebush, T; Wafi, AM; Yu, L; Zhou, W; Zucker, IH | 1 |
| Bai, Y; Jiang, X; Liu, P; Meng, L; Su, X; Wang, S; Xin, Y; Yang, G; Zhang, H | 1 |
| Jiang, X; Liu, W; Meng, L; Tian, Y; Wang, H; Xin, Y; Zhang, Q | 1 |
| Jiang, X; Li, J; Meng, L; Tian, Y; Wang, H; Xin, Y; Yang, G | 1 |
| Barile, L; Biemmi, V; Casieri, V; Chincoli, LR; Di Lascio, N; Faita, F; Furini, G; Lionetti, V; Matteucci, M; Milano, G; Papini, G | 1 |
9 other study(ies) available for angiotensin ii and sulforaphane
| Article | Year |
|---|---|
Sulforaphane protects H9c2 cardiomyocytes from angiotensin II-induced hypertrophy.
Topics: Angiotensin II; Animals; Cardiotonic Agents; Cell Line; Cell Size; Cell Survival; Dose-Response Relationship, Drug; Hypertrophy, Left Ventricular; Isothiocyanates; Myocytes, Cardiac; NF-kappa B; Oncogene Protein v-akt; Rats; Sulfoxides; Treatment Outcome | 2014 |
Sulforaphane Prevents Angiotensin II-Induced Testicular Cell Death via Activation of NRF2.
Topics: Angiotensin II; Animals; Anticarcinogenic Agents; Apoptosis; Blotting, Western; Disease Models, Animal; Immunohistochemistry; Infertility, Male; Isothiocyanates; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; NF-E2-Related Factor 2; Oxidative Stress; Reverse Transcriptase Polymerase Chain Reaction; Sulfoxides; Testis | 2017 |
Sulforaphane prevents angiotensin II-induced cardiomyopathy by activation of Nrf2 via stimulating the Akt/GSK-3ß/Fyn pathway.
Topics: Angiotensin II; Animals; Diabetic Cardiomyopathies; Disease Models, Animal; Glycogen Synthase Kinase 3 beta; Heart; Humans; Isothiocyanates; Male; Mice, Knockout; NF-E2-Related Factor 2; Oxidative Stress; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-fyn; Signal Transduction; Sulfoxides | 2018 |
Sulforaphane Attenuates Angiotensin II-Induced Vascular Smooth Muscle Cell Migration via Suppression of NOX4/ROS/Nrf2 Signaling.
Topics: Angiotensin II; Cell Movement; Cells, Cultured; Enzyme-Linked Immunosorbent Assay; Humans; Isothiocyanates; Muscle, Smooth, Vascular; NADPH Oxidase 4; NADPH Oxidases; NF-E2-Related Factor 2; Reactive Oxygen Species; RNA, Small Interfering; Signal Transduction; Sulfoxides; Transcription Factor RelA; Wound Healing | 2019 |
Overexpression of Central ACE2 (Angiotensin-Converting Enzyme 2) Attenuates the Pressor Response to Chronic Central Infusion of Ang II (Angiotensin II): A Potential Role for Nrf2 (Nuclear Factor [Erythroid-Derived 2]-Like 2).
Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Blood Pressure; Cell Line, Tumor; Isothiocyanates; Mice; Mice, Transgenic; NF-E2-Related Factor 2; Oxidative Stress; Proto-Oncogene Mas; Reactive Oxygen Species; Sulfoxides; Up-Regulation | 2020 |
Sulforaphane prevents angiotensin II-induced cardiomyopathy by activation of Nrf2 through epigenetic modification.
Topics: Angiotensin II; Animals; Cardiomyopathies; Epigenesis, Genetic; Gene Expression Regulation; Isothiocyanates; Male; Mice; Mice, Inbred C57BL; NF-E2-Related Factor 2; Oxidative Stress; Sulfoxides; Vasoconstrictor Agents | 2021 |
Essential role of Nrf2 in sulforaphane-induced protection against angiotensin II-induced aortic injury.
Topics: Angiotensin II; Animals; Glycogen Synthase Kinase 3 beta; Inflammation; Isothiocyanates; Mice; Mice, Inbred C57BL; Mice, Knockout; NF-E2-Related Factor 2; Oxidative Stress; Sulfoxides | 2022 |
Sulforaphane inhibits angiotensin II-induced cardiomyocyte apoptosis by acetylation modification of Nrf2.
Topics: Acetylation; Angiotensin II; Animals; Antioxidants; Apoptosis; Isothiocyanates; Myocytes, Cardiac; NF-E2-Related Factor 2; Oxidative Stress; Rats; Sulfoxides | 2022 |
Cardiomyocyte-targeting exosomes from sulforaphane-treated fibroblasts affords cardioprotection in infarcted rats.
Topics: Angiotensin II; Animals; Antibodies; Exosomes; Fibroblasts; Isothiocyanates; Male; Mice; Myocytes, Cardiac; Rats; Rats, Wistar | 2023 |